Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Genetic suppression of IKK2/NF-κB in astrocytes inhibits neuroinflammation and reduces neuronal loss in the MPTP-Probenecid model of Parkinson's disease.

Kirkley KS, Popichak KA, Hammond SL, Davies C, Hunt L, Tjalkens RB.

Neurobiol Dis. 2019 Jul;127:193-209. doi: 10.1016/j.nbd.2019.02.020. Epub 2019 Feb 25.

PMID:
30818064
2.

Compensatory Expression of Nur77 and Nurr1 Regulates NF-κB-Dependent Inflammatory Signaling in Astrocytes.

Popichak KA, Hammond SL, Moreno JA, Afzali MF, Backos DS, Slayden RD, Safe S, Tjalkens RB.

Mol Pharmacol. 2018 Oct;94(4):1174-1186. doi: 10.1124/mol.118.112631. Epub 2018 Aug 15.

3.

The Nurr1 Ligand,1,1-bis(3'-Indolyl)-1-(p-Chlorophenyl)Methane, Modulates Glial Reactivity and Is Neuroprotective in MPTP-Induced Parkinsonism.

Hammond SL, Popichak KA, Li X, Hunt LG, Richman EH, Damale PU, Chong EKP, Backos DS, Safe S, Tjalkens RB.

J Pharmacol Exp Ther. 2018 Jun;365(3):636-651. doi: 10.1124/jpet.117.246389. Epub 2018 Apr 6.

4.

Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.

Hammond SL, Leek AN, Richman EH, Tjalkens RB.

PLoS One. 2017 Dec 15;12(12):e0188830. doi: 10.1371/journal.pone.0188830. eCollection 2017.

5.

Entry Sites of Venezuelan and Western Equine Encephalitis Viruses in the Mouse Central Nervous System following Peripheral Infection.

Phillips AT, Rico AB, Stauft CB, Hammond SL, Aboellail TA, Tjalkens RB, Olson KE.

J Virol. 2016 May 27;90(12):5785-96. doi: 10.1128/JVI.03219-15. Print 2016 Jun 15.

6.

A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro.

Hammond SL, Safe S, Tjalkens RB.

Neurosci Lett. 2015 Oct 21;607:83-89. doi: 10.1016/j.neulet.2015.09.015. Epub 2015 Sep 14.

7.

Angiotensin II regulates brain (pro)renin receptor expression through activation of cAMP response element-binding protein.

Li W, Liu J, Hammond SL, Tjalkens RB, Saifudeen Z, Feng Y.

Am J Physiol Regul Integr Comp Physiol. 2015 Jul 15;309(2):R138-47. doi: 10.1152/ajpregu.00319.2014. Epub 2015 May 20.

8.

The Nurr1 Activator 1,1-Bis(3'-Indolyl)-1-(p-Chlorophenyl)Methane Blocks Inflammatory Gene Expression in BV-2 Microglial Cells by Inhibiting Nuclear Factor κB.

De Miranda BR, Popichak KA, Hammond SL, Jorgensen BA, Phillips AT, Safe S, Tjalkens RB.

Mol Pharmacol. 2015 Jun;87(6):1021-34. doi: 10.1124/mol.114.095398. Epub 2015 Apr 9.

9.

Novel para-phenyl substituted diindolylmethanes protect against MPTP neurotoxicity and suppress glial activation in a mouse model of Parkinson's disease.

De Miranda BR, Popichak KA, Hammond SL, Miller JA, Safe S, Tjalkens RB.

Toxicol Sci. 2015 Feb;143(2):360-73. doi: 10.1093/toxsci/kfu236. Epub 2014 Nov 17.

10.

Integrin α3β1 controls mRNA splicing that determines Cox-2 mRNA stability in breast cancer cells.

Subbaram S, Lyons SP, Svenson KB, Hammond SL, McCabe LG, Chittur SV, DiPersio CM.

J Cell Sci. 2014 Mar 15;127(Pt 6):1179-89. doi: 10.1242/jcs.131227. Epub 2014 Jan 16.

11.

Mitotic phosphorylation of histone H3 threonine 80.

Hammond SL, Byrum SD, Namjoshi S, Graves HK, Dennehey BK, Tackett AJ, Tyler JK.

Cell Cycle. 2014;13(3):440-52. doi: 10.4161/cc.27269. Epub 2013 Nov 25.

12.

Fine structure of the giant M1 resonance in 90Zr.

Rusev G, Tsoneva N, Dönau F, Frauendorf S, Schwengner R, Tonchev AP, Adekola AS, Hammond SL, Kelley JH, Kwan E, Lenske H, Tornow W, Wagner A.

Phys Rev Lett. 2013 Jan 11;110(2):022503. Epub 2013 Jan 9.

PMID:
23383897
13.

Spectral structure of the pygmy dipole resonance.

Tonchev AP, Hammond SL, Kelley JH, Kwan E, Lenske H, Rusev G, Tornow W, Tsoneva N.

Phys Rev Lett. 2010 Feb 19;104(7):072501. Epub 2010 Feb 18.

PMID:
20366874
14.

Thoracic outlet syndrome: a review.

Sanders RJ, Hammond SL, Rao NM.

Neurologist. 2008 Nov;14(6):365-73. doi: 10.1097/NRL.0b013e318176b98d. Review.

PMID:
19008742
15.

Observations on the use of seprafilm on the brachial plexus in 249 operations for neurogenic thoracic outlet syndrome.

Sanders RJ, Hammond SL, Rao NM.

Hand (N Y). 2007 Dec;2(4):179-83. doi: 10.1007/s11552-007-9044-4. Epub 2007 May 3.

16.

Diagnosis of thoracic outlet syndrome.

Sanders RJ, Hammond SL, Rao NM.

J Vasc Surg. 2007 Sep;46(3):601-4. Review.

17.

Supraclavicular total scalenectomy with or without first rib resection: technic and results.

Sanders RJ, Hammond SL.

Handchir Mikrochir Plast Chir. 2006 Feb;38(1):29-36.

PMID:
16538569
18.

Subclavian vein obstruction without thrombosis.

Sanders RJ, Hammond SL.

J Vasc Surg. 2005 Feb;41(2):285-90.

19.

Genetic analysis of lice supports direct contact between modern and archaic humans.

Reed DL, Smith VS, Hammond SL, Rogers AR, Clayton DH.

PLoS Biol. 2004 Nov;2(11):e340. Epub 2004 Oct 5.

20.

Venous thoracic outlet syndrome.

Sanders RJ, Hammond SL.

Hand Clin. 2004 Feb;20(1):113-8, viii. Review.

PMID:
15005393
21.

Supraclavicular first rib resection and total scalenectomy: technique and results.

Sanders RJ, Hammond SL.

Hand Clin. 2004 Feb;20(1):61-70. Review.

PMID:
15005386
22.

Etiology and pathology.

Sanders RJ, Hammond SL.

Hand Clin. 2004 Feb;20(1):23-6. Review.

PMID:
15005380
23.
24.
25.

Outcome of surgery for thoracic outlet syndrome in Washington state workers' compensation.

Sanders RJ, Hammond SL.

Neurology. 2000 Nov 28;55(10):1594-5. No abstract available.

PMID:
11094131
26.

Indium In-111 pentetreotide scintigraphy: application to carotid body tumors.

Hammond SL, Greco DL, Lambert AT, McBiles M, Patton GM.

J Vasc Surg. 1997 May;25(5):905-8.

27.

Supra-aortic arterial stenoses: management with Palmaz balloon-expandable intraluminal stents.

Lyon RD, Shonnard KM, McCarter DL, Hammond SL, Ferguson D, Rholl KS.

J Vasc Interv Radiol. 1996 Nov-Dec;7(6):825-35.

PMID:
8951749
28.

Response of serum cytokines in patients undergoing laparoscopic cholecystectomy.

Cho JM, LaPorta AJ, Clark JR, Schofield MJ, Hammond SL, Mallory PL 2nd.

Surg Endosc. 1994 Dec;8(12):1380-3; discussion 1383-4.

PMID:
7878501
29.

Digital vasculitis associated with interferon therapy.

Reid TJ 3rd, Lombardo FA, Redmond J 3rd, Hammond SL, Coffey JA, Ozer H.

Am J Med. 1992 Jun;92(6):702-3. No abstract available.

PMID:
1605155
30.

Communicating about environmental risks: how the public uses and perceives information sources.

McCallum DB, Hammond SL, Covello VT.

Health Educ Q. 1991 Fall;18(3):349-61. No abstract available.

PMID:
1917510
31.

Health advertising: prevention for profit.

Freimuth VS, Hammond SL, Stein JA.

Am J Public Health. 1988 May;78(5):557-61.

32.

The gatekeeping funnel: tracking a major PSA campaign from distribution through gatekeepers to target audience.

Hammond SL, Freimuth VS, Morrison W.

Health Educ Q. 1987 Summer;14(2):153-66.

PMID:
3597108
33.
34.

Improved medium for clonal growth of human diploid fibroblasts at low concentrations of serum protein.

McKeehan WL, McKeehan KA, Hammond SL, Ham RG.

In Vitro. 1977 Jul;13(7):399-416.

PMID:
301851
35.

Supplemental Content

Loading ...
Support Center